Abstract
Aim: To investigate the biological fate of cuprous oxide nanoparticles (Cu2O-NPs) and to evaluate their potential in uveal melanoma therapy. Materials & methods: The protein corona, cellular uptake mechanism and localization of Cu2O-NPs were investigated. Furthermore, the effect of Cu2O-NPs on uveal melanoma cell proliferation, migration and invasion, and possible mechanisms were studied in detail. Results: Cu2O-NPs are able to adsorb serum proteins in cell culture medium, which are then internalized by uveal melanoma cells mainly through lipid raft-mediated endocytosis. Furthermore, Cu2O-NPs selectively inhibit cancer cell growth and impair the ability of uveal melanoma cell migration, invasion and the cytoskeleton assembly. The mechanism may be that Cu2O-NPs located in and damage mitochondria, autophagolysosomes and lysosomes, leading to elevated reactive oxygen species level and over-stimulated apoptosis and autophagy. Conclusion: The data provide detailed information of Cu2O-NPs for further application and indicate that Cu2O-NPs could be a potential agent for uveal melanoma therapy.
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1 . Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology 118(9), 1881–1885 (2011).
- 2 . Variates of survival in metastatic uveal melanoma. J. Clin. Oncol. 23(31), 8076–8080 (2005).
- 3 . Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications. Curr. Opin. Biotechnol. 24(6), 1159–1166 (2013).• Comprehensive review on the progress of nanomedicine.
- 4 . Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J. Am. Chem. Soc. 134(4), 2139–2147 (2012).
- 5 . (Intra) cellular stability of inorganic nanoparticles: effects on cytotoxicity, particle functionality, and biomedical applications. Chem. Rev. 115(5), 2109–2135 (2015).
- 6 . Crystal-plane-dependent etching of cuprous oxide nanoparticles of varied shapes and their application in visible light photocatalysis. J. Phys. Chem. C 117(46), 24640–24653 (2013).
- 7 Cuprous oxide nanoparticles dispersed on reduced graphene oxide as an efficient electrocatalyst for oxygen reduction reaction. Chem. Commun. 48(13), 1892–1894 (2012).
- 8 Reduced graphene oxide conjugated Cu2O nanowire mesocrystals for high-performance NO2 gas sensor. J. Am. Chem. Soc. 134(10), 4905–4917 (2012).
- 9 . Copper oxide nanoparticles induce autophagic cell death in A549 cells. PLoS ONE 7(8), e43442 (2012).
- 10 . Copper oxide nanoparticles induced mitochondria mediated apoptosis in human hepatocarcinoma cells. PLoS ONE 8(8), e69534 (2013).
- 11 . Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. Chem. Res. Toxicol. 21(9), 1726–1732 (2008).
- 12 . Copper oxide nanoparticles induce oxidative stress and cytotoxicity in airway epithelial cells. Toxicol. In Vitro 23(7), 1365–1371 (2009).
- 13 Cuprous oxide nanoparticles selectively induce apoptosis of tumor cells. Int. J. Nanomed. 7, 2641–2652 (2012).
- 14 Cuprous oxide nanoparticles inhibit the growth and metastasis of melanoma by targeting mitochondria. Cell Death Dis. 4(8), e783 (2013).• Cu2O-NPs suppress the growth and metastasis of cutaneous melanoma in vivo with little toxicity.
- 15 . Cytotoxicity of cuprous oxide nanoparticles to fish blood cells: hemolysis and internalization. J. Nanopart. Res. 15(3), 1–9 (2013).
- 16 . Effects of serum adsorption on cellular uptake profile and consequent impact of titanium dioxide nanoparticles on human lung cell lines. ACS Nano 6(5), 4083–4093 (2012).
- 17 Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat. Nanotechnol. 8(10), 772–781 (2013).
- 18 . Protein corona formation around nanoparticles–from the past to the future. Materials Horizons 1(3), 301–313 (2014).
- 19 Protein corona of nanoparticles: distinct proteins regulate the cellular uptake. Biomacromolecules 16(4), 1311–1321 (2015).
- 20 . Endocytosis of gene delivery vectors: from clathrin-dependent to lipid raft-mediated endocytosis. Mol. Ther. 21(6), 1118–1130 (2013).
- 21 . Autophagy and apoptosis: where do they meet? Apoptosis 19(4), 555–566 (2014).
- 22 Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif. 45(6), 487–498 (2012).
- 23 . Autophagy and cancer therapy. Autophagy 2(2), 85–90 (2006).
- 24 . Manganese nanoparticle activates mitochondrial dependent apoptotic signaling and autophagy in dopaminergic neuronal cells. Toxicol. Appl. Pharmacol. 256(3), 227–240 (2011).
- 25 Interplay between autophagy and apoptosis mediated by copper oxide nanoparticles in human breast cancer cells MCF7. Biochim. Biophys. Acta 1840(1), 1–9 (2014).
- 26 . Cuprous oxide nanoparticles inhibit angiogenesis via down regulation of VEGFR2 expression. Nanoscale 6(6), 3206–3216 (2014).
- 27 . Cuprous oxide nanospheres as probes for light scattering imaging analysis of live cells and for conformation identification of proteins. Talanta 80(3), 1400–1405 (2010).•• The initial investigation revealing the medical potential of Cu2O-NPs.
- 28 . Nanoparticle–protein corona complexes govern the biological fates and functions of nanoparticles. J. Mater. Chem. B 2(15), 2060–2083 (2014).• Comprehensive review on the progress of protein corona.
- 29 . Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases. Retina 32(7), 1363–1372 (2012).
- 30 . A perspective on cancer cell metastasis. Science 331(6024), 1559–1564 (2011).
- 31 Metabolic stress regulates cytoskeletal dynamics and metastasis of cancer cells. J. Clin. Invest. 123(7), 2907 (2013).
- 32 . The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu. Rev. Biomed. Eng. 14, 1–16 (2012).
- 33 . Mitochondria: dynamic organelles in disease, aging, and development. Cell 125(7), 1241–1252 (2006).
- 34 . Mitochondria in health and disease: perspectives on a new mitochondrial biology. Mol. Aspects Med. 25(4), 365–451 (2004).
- 35 Mapping the biological oxidative damage of engineered nanomaterials. Small 9(9–10), 1853–1865 (2013).
- 36 . Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell. Signal. 24(5), 981–990 (2012).
- 37 . Mitochondria, oxidants, and aging. Cell 120(4), 483–495 (2005).
- 38 . Caspase activation cascades in apoptosis. Biochem. Soc. Trans. 36(Pt 1), 1–9 (2008).
- 39 . Analysis of apoptosis by cytometry using TUNEL assay. Methods 44(3), 250–254 (2008).
- 40 . Caspases in apoptosis and beyond. Oncogene 27(48), 6194–6206 (2008).
- 41 Advances in using PARP inhibitors to treat cancer. BMC Med. 10(1), 25 (2012).
- 42 . Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol. Cell. Biochem. 351(1–2), 41–58 (2011).
- 43 The pro-apoptotic proteins, Bid and Bax, cause a limited permeabilization of the mitochondrial outer membrane that is enhanced by cytosol. J. Cell Biol. 147(4), 809–822 (1999).
- 44 . Autophagic cell death exists. Autophagy 8(6), 867–869 (2012).
- 45 . Autophagy suppresses melanoma tumorigenesis by inducing senescence. Autophagy 10(2), 372–373 (2014).
- 46 p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem. 282(33), 24131–24145 (2007).
- 47 Gold nanoparticles induce autophagosome accumulation through size-dependent nanoparticle uptake and lysosome impairment. ACS Nano 5(11), 8629–8639 (2011).• The investigation first revealed that nanoparticle-induced autophagy might result from impairment of lysosomes.
- 48 . Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discov. 7(9), 771–782 (2008).
- 49 . Cancer cell metabolism: one hallmark, many faces. Cancer Discov. 2(10), 881–898 (2012).
- 50 Selective targeting of gold nanorods at the mitochondria of cancer cells: implications for cancer therapy. Nano Lett. 11(2), 772–780 (2010).
- 51 . Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species. Int. J. Nanomed. 7, 845 (2012).
- 52 . Serum heat inactivation affects protein corona composition and nanoparticle uptake. Biomaterials 31(36), 9511–9518 (2010).
- 53 . Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano 6(7), 5845–5857 (2012).
- 54 . Lipid raft: a floating island of death or survival. Toxicol. Appl. Pharmacol. 259(3), 311–319 (2012).
- 55 . Lipid rafts, caveolae, and their endocytosis. Int. Rev. Cell Mol. Biol. 282, 135–163 (2010).
- 56 . Mechanisms of quantum dot nanoparticle cellular uptake. Toxicol. Sci. 110(1), 138–155 (2009).
- 57 Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. ACS Nano 8(3), 2439–2455 (2014).•• Extensive investigation revealing the significant role of protein corona in cell–nanoparticle interaction.
- 58 . ROS-induced mitochondrial depolarization initiates PARK2/PARKIN-dependent mitochondrial degradation by autophagy. Autophagy 8(10), 1462–1476 (2012).
- 59 Reactive oxygen species (ROS) mediates the mitochondrial-dependent apoptosis induced by transforming growth factor β in fetal hepatocytes. FASEB J. 15(3), 741–751 (2001).
- 60 . Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat. Rev. Mol. Cell Biol. 8(9), 741–752 (2007).
- 61 Exploiting intrinsic nanoparticle toxicity: the pros and cons of nanoparticle-induced autophagy in biomedical research. Chem. Rev. 114(15), 7581–7609 (2014).